THERAPEUTIC TARGETING (THETA)
Live / Applied — New application — not yet assigned to an examiner (as of 13 Jan 2026)
What this means for you
Not registered yet, but its 13 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99591522
- Mark type
- Stylized text
- Filed
- 13 Jan 2026
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Drug delivery agents consisting of antibodies or antibody fragments, sold as an integral component of pharmaceuticals; Antibodies or antibody fragments for medical purposes; Antibody or antibody fragment-containing compounds for medical purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Korsana Biosciences, Inc., Waltham, MA, US
Prosecution history
- 13 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 13 Jan 2026 — NEW APPLICATION ENTERED